---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-258490"
form_type: "8-K"
ticker: null
cik: "0001538210"
company_name: "NexImmune, Inc."
filed_at: "2023-10-18T23:59:59+00:00"
generated_at: "2026-06-09T21:48:47.243245+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NexImmune announces 1-for-25 reverse stock split effective Oct 18, 2023 to regain Nasdaq compliance

## Summary
- Reverse stock split at 1-for-25 ratio effective after market close on Oct 18, 2023.
- Shares outstanding reduced from ~26.5M to ~1.06M; authorized shares unchanged at 100M.
- Stockholders approved split at special meeting on Oct 17, 2023 (13.8M for, 344K against).
- Split is intended to regain minimum bid price compliance on Nasdaq Capital Market.
- Fractional shares cashed out at closing price on Oct 18; CUSIP changes to 65344D 208.

## SEC filing metadata
- accession: 0001193125-23-258490
- form_type: 8-K
- cik: 0001538210
- company_name: NexImmune, Inc.
- filed_at: 2023-10-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1538210/000119312523258490/0001193125-23-258490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1538210/000119312523258490/d331798d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-258490
- JSON: https://secwatch.observer/filing/0001193125-23-258490.json
- Plain text: https://secwatch.observer/filing/0001193125-23-258490.txt

## Key facts
- Governance Changes
  NexImmune, Inc.: Reverse stock split at 1-for-25 ratio, effective after close of trading on October 18, 2023 (effective 2023-10-18).
  - Change: charter amendment
  - Effective: 2023-10-18
  source text: On October 18, 2023, the Company filed with the Secretary of State of the State of Delaware the Certificate of Amendment to effect a one-time reverse stock split of the Company’s common stock, at a ratio of 1-for-25 (the “Reverse Stock Split”). The Reverse Stock Split was effective at 5 p.m. Eastern Time, after the close of trading on the Nasdaq Capital Market, on October 18, 2023 (the “Effective Time”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312523258490/0001193125-23-258490-index.htm
- Shareholder Votes
  NexImmune, Inc. shareholders approved Approval of adjournment of the special meeting to solicit additional proxies if necessary. at the 2023-10-17 meeting.
  - Outcome: passed
  - Meeting: 2023-10-17
  source text: Votes For Votes Against Votes Abstained 13,899,330 286,293 88,853
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312523258490/0001193125-23-258490-index.htm
- Shareholder Votes
  NexImmune, Inc. shareholders approved Approval of amendment to certificate of incorporation to effect a reverse stock split at a ratio of not less than 1-for-4 and not more than 1-for-50, with exact ratio set by board. at the 2023-10-17 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-10-17
  source text: Votes For Votes Against Votes Abstained 13,838,206 344,220 92,050
  evidence_url: https://www.sec.gov/Archives/edgar/data/1538210/000119312523258490/0001193125-23-258490-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.